1. Home
  2. AMRX vs MTX Comparison

AMRX vs MTX Comparison

Compare AMRX & MTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • MTX
  • Stock Information
  • Founded
  • AMRX 2002
  • MTX 1968
  • Country
  • AMRX United States
  • MTX United States
  • Employees
  • AMRX N/A
  • MTX N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • MTX Major Chemicals
  • Sector
  • AMRX Health Care
  • MTX Industrials
  • Exchange
  • AMRX Nasdaq
  • MTX Nasdaq
  • Market Cap
  • AMRX 2.5B
  • MTX 2.4B
  • IPO Year
  • AMRX N/A
  • MTX 1992
  • Fundamental
  • Price
  • AMRX $8.01
  • MTX $78.67
  • Analyst Decision
  • AMRX Strong Buy
  • MTX Strong Buy
  • Analyst Count
  • AMRX 5
  • MTX 1
  • Target Price
  • AMRX $10.00
  • MTX $97.00
  • AVG Volume (30 Days)
  • AMRX 1.1M
  • MTX 127.6K
  • Earning Date
  • AMRX 11-08-2024
  • MTX 01-30-2025
  • Dividend Yield
  • AMRX N/A
  • MTX 0.55%
  • EPS Growth
  • AMRX N/A
  • MTX 138.40
  • EPS
  • AMRX N/A
  • MTX 4.71
  • Revenue
  • AMRX $2,680,420,000.00
  • MTX $2,124,900,000.00
  • Revenue This Year
  • AMRX $17.86
  • MTX N/A
  • Revenue Next Year
  • AMRX $3.90
  • MTX $5.22
  • P/E Ratio
  • AMRX N/A
  • MTX $16.93
  • Revenue Growth
  • AMRX 12.32
  • MTX N/A
  • 52 Week Low
  • AMRX $5.01
  • MTX $64.79
  • 52 Week High
  • AMRX $9.48
  • MTX $90.30
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 42.36
  • MTX 45.14
  • Support Level
  • AMRX $7.68
  • MTX $78.45
  • Resistance Level
  • AMRX $8.18
  • MTX $80.28
  • Average True Range (ATR)
  • AMRX 0.29
  • MTX 1.66
  • MACD
  • AMRX -0.04
  • MTX -0.40
  • Stochastic Oscillator
  • AMRX 25.41
  • MTX 10.71

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About MTX Minerals Technologies Inc.

Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into three segments based on product type. The specialty minerals segment, sells calcium carbonate, limestone, and talc, which is used in the paper, building materials, paint, automotive, and pharmaceutical industries. The refractories segment sells products for steel furnaces. The performance materials segment sells bentonite used in steel alloy casting and household products including cat litter. The majority of revenue comes from the United States.

Share on Social Networks: